{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Irm", "item": "https://www.patentleaderboard.com/2021/company/irm"}, {"@type": "ListItem", "position": 4, "name": "Daniel Mutnick", "item": "https://www.patentleaderboard.com/2021/inventor/fl:da_ln:mutnick-1"}]}

Home › 2021 › Irm › Daniel Mutnick

Daniel Mutnick — 1 Patent in 2021

Novartis Ag: 1 patents #117 of 519Top 25%

Concord, CA: #22 of 73 inventorsTop 35%

California: #26,007 of 66,859 inventorsTop 40%

Overall (2021): #481,378 of 548,734Top 90%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10954233	Compounds and compositions as inhibitors of endosomal toll-like receptors	Phillip Alper, Jonathan Deane, Songchun Jiang, Tao Jiang, Thomas Knoepfel +5 more	2021-03-23	$32,746,000

Daniel Mutnick — 1 Patent in 2021

Issued Patents 2021

Patent Widget